Literature DB >> 12489996

High-level erythroid lineage-directed gene expression using globin gene regulatory elements after lentiviral vector-mediated gene transfer into primitive human and murine hematopoietic cells.

Hideki Hanawa1, Derek A Persons, Arthur W Nienhuis.   

Abstract

Lentiviral vectors efficiently transduce primitive human hematopoietic cells and are capable of transferring complex genomes. Vectors were designed with hypersensitive sites containing regulatory elements from the beta-globin locus control region linked to the beta-globin gene promoter to drive expression of the enhanced green fluorescent protein marker to facilitate analysis of the pattern of gene expression in various hematopoietic lineages. Such vectors gave higher level, induced expression in mouse erythroleukemia cells than a previously described vector that utilized an enhancer from the alpha locus and the ankyrin-1 promoter [Moreau-Gaudry, F., Xia, P., Jiang, G., Perelman, N.P., Bauer, G., Ellis, J., Surinya, K.H., Mavilio, F., Shen, C.K., and Malik, P. (2001). Blood 98, 2664-2672]. The addition of gamma-globin intron sequences further augmented vector expression. Expression was also effectively targeted to the erythroid lineage in cultured human cells from peripheral blood and in mouse red blood cells in vivo, although lower levels of expression were also observed in other lineages. Thus, these newly described vectors provide a means to achieve high-level gene expression, predominantly in erythroid cells, an outcome that may have potential therapeutic application.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12489996     DOI: 10.1089/10430340260395866

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  6 in total

1.  Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element.

Authors:  Hideki Hanawa; Motoko Yamamoto; Huifen Zhao; Takashi Shimada; Derek A Persons
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

2.  A transcriptome-based examination of blood group expression.

Authors:  S-J Noh; Y T Lee; C Byrnes; J L Miller
Journal:  Transfus Clin Biol       Date:  2010-08-03       Impact factor: 1.406

3.  Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixafor.

Authors:  Naoya Uchida; Aylin Bonifacino; Allen E Krouse; Mark E Metzger; Gyorgy Csako; Agnes Lee-Stroka; Ross M Fasano; Susan F Leitman; Joseph J Mattapallil; Matthew M Hsieh; John F Tisdale; Robert E Donahue
Journal:  Exp Hematol       Date:  2011-04-15       Impact factor: 3.084

4.  An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation.

Authors:  Byoung Y Ryu; Marguerite V Evans-Galea; John T Gray; David M Bodine; Derek A Persons; Arthur W Nienhuis
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

5.  In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene.

Authors:  Andre Larochelle; Uimook Choi; Yan Shou; Nora Naumann; Natalia A Loktionova; Joshua R Clevenger; Allen Krouse; Mark Metzger; Robert E Donahue; Elizabeth Kang; Clinton Stewart; Derek Persons; Harry L Malech; Cynthia E Dunbar; Brian P Sorrentino
Journal:  J Clin Invest       Date:  2009-06-08       Impact factor: 14.808

6.  Beta-globin LCR and intron elements cooperate and direct spatial reorganization for gene therapy.

Authors:  Alla Buzina; Mandy Y M Lo; Angela Moffett; Akitsu Hotta; Eden Fussner; Rikki R Bharadwaj; Peter Pasceri; J Victor Garcia-Martinez; David P Bazett-Jones; James Ellis
Journal:  PLoS Genet       Date:  2008-04-11       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.